Adult epilepsy

  title={Adult epilepsy},
  author={John S. Duncan and Josemir W Sander and Sanjay M. Sisodiya and Matthew C. Walker},
  journal={The Lancet},

Figures and Tables from this paper

Modern management of epilepsy: A practical approach

The heart of epilepsy: Current views and future concepts

The fascinating borderland of epilepsy and cardiovascular conditions is discussed, focusing on epidemiology, clinical presentations and possible mechanisms for shared pathophysiology, and a call for validated screening instruments and guidelines aiding the early treatment of CV comorbidity in epilepsy.

What can be done to reduce the risk of SUDEP ?

Understanding of the best way to prevent sudden unexplained death in epilepsy is still incomplete, but it is clear that SUDEP is mainly (but not exclusively) a problem for people with chronic uncontrolled epilepsy.

Epilepsy in later life

Epilepsy treatment: a paradigm shift is urgently need.

Once epileptogenesis is fully understood, treatment can be targeted at specific mechanisms, and then the authors will have truly disease-modifying therapies, the hope for the future is a shift of paradigm away from the symptomatic approach that currently exists.

Epilepsy in Elderly Population: A Comprehensive Review

Older patients most often present with focal seizures, with less prominent auras and automatisms, and longer duration of postictal confusion, and care should be taken when prescribing anticonvulsants in this age group to minimize the drug side effects.

The brain-heart connection: implications for understanding sudden unexpected death in epilepsy.

It is suggested that sudden unexpected death in epilepsy (SUDEP) could be related to the occurrence of specific brain structure dysfunction or anatomical change, at least in some cases.

Personalized medicine in epilepsy patients

The established evidence regarding pharmacogenomics in epilepsy is summarized, the basis of precision medicine is discussed and two methods, genome-wide analyses and next-generation sequencing, are discussed.

Inflammation: Cause or Consequence of Epilepsy?

The involvement of inflammatory mediators in the development and progression of seizures and epileptogenesis is discussed, supported by clinical shreds of evidence, and the role of inflammation in the generation of seizures is discussed.

Diabetes and Epilepsy in Children and Adolescents

Several mechanisms could explain the occurrence of epilepsy in young people with T1D, such as metabolic abnormalities (hypo/hyperglycemia) and autoantibodies, along with a genetic predisposition and the presence of brain lesions/damage.



Analysis of Genetically Complex Epilepsies

Future studies should employ very large sample sizes to ensure adequate statistical power, clinical phenotyping methods of the highest quality, designs and analytic techniques that control for population stratification, and state-of-the‐art molecular methods.

ILAE Genetics Commission Conference Report: Molecular Analysis of Complex Genetic Epilepsies

Most gene discoveries over the last 6-year period have been confined to epilepsies showing single-gene inheritance, and many occur in pedigrees too small or few in number to allow successful gene localization.

Genetics of the epilepsies

Purpose of reviewThis article reviews the most significant advances in the field of genetics of the epilepsies during the past year, with emphasis on newly identified genes and functional studies

Genetic Association Studies in Epilepsy: “The Truth Is Out There”

It is cautiously optimistic that with methodologic refinements and multicenter collaborations with large sample sizes, association studies will ultimately be useful in dissecting the genetic basis of common epilepsy syndromes.

Reducing mortality: an important aim of epilepsy management

  • J. SanderG. Bell
  • Medicine, Psychology
    Journal of Neurology, Neurosurgery & Psychiatry
  • 2004
The mortality of people with epilepsy is not uniform over the lifetime of a person with epilepsy, nor across different populations, but there are some specific ways in which mortality differs.

The treatment of epilepsy in developing countries: where do we go from here?

There have been successful attempts to provide treatment, which have shown the importance of community-based approaches and also indicate that provision for sustained intervention over the long term is necessary in any treatment programme.

Genetic Malformations of the Cerebral Cortex and Epilepsy

X‐linked bilateral periventricular nodular heterotopia (BPNH) consists of typical BPNH with epilepsy in female patients and prenatal lethality in most males, and bilateral perisylvian polymicrogyria shows genetic heterogeneity, including linkage to Xq28 in some pedigrees, autosomal recessive inheritance in others, and association with 22q11.2 deletion in some patients.

The epidemiology of epilepsy revisited

There is geographic variation in the incidence of epileptic syndromes likely to be associated with genetic and environmental factors, although as yet causality has not been fully established.

The natural history of epilepsy: an epidemiological view

Observations from complementary sources suggest that, at the population level, prognosis of newly diagnosed epilepsy may be broadly categorised into three groups: remission without treatment, remission with treatment only, and persistent seizures despite treatment.

Disease modification in partial epilepsy.

Data from animal experiments suggest that treatment of non-convulsive status epilepticus following specific insults may prevent epileptogenesis, and the concept of a latent period during which there could be targeted therapies to prevent the epileptogenic process is supported.